AGIOS PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities in USD from 2011 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to Q1 2025.
  • Agios Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $1.62M, a 72.4% decline year-over-year.
  • Agios Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $14.4M, a 166% increase from 2023.
  • Agios Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5.43M, a 131% increase from 2022.
  • Agios Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2.35M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

AGIOS PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $1.62M -$4.25M -72.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q1 2024 $5.86M +$3.4M +138% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q1 2023 $2.47M +$1.26M +104% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $1.21M -$6.05M -83.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $7.26M +$1.88M +34.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $5.39M +$525K +10.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q1 2019 $4.86M -$523M -99.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q1 2018 $528M +$524M +12957% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2017 $4.05M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04

AGIOS PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $14.4M +$9.01M +166% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 $5.43M +$3.08M +131% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 $2.35M +$768M Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2021 -$766M -$1.03B -393% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $262M -$28.1M -9.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $290M -$256M -47% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $546M +$261M +91.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $285M +$115M +67.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 $170M +$163M +2564% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 $6.37M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-14
2013 $124M +$124M +87139% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-18
2012 $142K -$77.2M -99.8% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-18
2011 $77.4M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.